Who are Perspective Therapeutics, Inc.'s main suppliers?

Perspective Therapeutics, Inc. (CATX) key suppliers include: U-S-DEPARTMENT-OF-ENERGY, COMECER-SPA, Lantheus Holdings, Inc.. View the full supplier network at chainsifter.com/chain/CATX.

Who are Perspective Therapeutics, Inc.'s major customers?

Perspective Therapeutics, Inc. (CATX) key customers include: Lantheus Holdings, Inc.. View the full customer network at chainsifter.com/chain/CATX.

What sector is Perspective Therapeutics, Inc. in?

Perspective Therapeutics, Inc. (CATX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CATX Supply Chain: Perspective Therapeutics, Inc. Supplier List & 7 Relationships

3Suppliers

1Customers

3Debt Items

17Related Chains

Perspective Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
U-S-DEPARTMENT-OF-ENERGY	U-S-DEPARTMENT-OF-ENERGY	92%	In May 2025 and May 2026, we entered into supply agreements with the U.S. Department of Energy (DOE) under which we will purchase Thorium-228 from the DOE between 2025 and 2027.
COMECER-SPA	COMECER-SPA	90%	In 2024, we entered into a Master Equipment and Services Agreement (MESA) and statements of work (SOWs) thereunder with Comecer SpA (Comecer), pursuant to which we agreed to purchase from Comecer man…
LNTH	Lantheus Holdings, Inc.	72%	Reciprocal relationship from LNTH graph: Reciprocal relationship from CATX graph: Reciprocal relationship from LNTH graph: Reciprocal relationship from CATX graph: Reciprocal relationship from LNTH g…

Perspective Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
LNTH	Lantheus Holdings, Inc.	72%	Reciprocal relationship from LNTH graph: tion and the potential that efforts to extend or secure separate or otherwise adequate payment for radiopharmaceutical diagnostics are unsuccessful. • The ext…

Perspective Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CATX-DEBT-8488	Warrants outstanding: 0	90%	xbrl warrant detail from xbrl 2025-12-31.
CATX-DEBT	Debt stack $4.2M	90%	Market cache reports total debt of $4.2M.
CATX-DEBT-8489	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-06-30.

Perspective Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Perspective Therapeutics, Inc..

Perspective Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
CATX-OWNER-AVIDITY-PARTNERS-MANAGEMENT-LP	Avidity Partners Management LP	90%	13F overlay lists Avidity Partners Management LP as top holder; 137 tracked holders.

Perspective Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LNTH	Lantheus Holdings, Inc.	100.00	2	['customer', 'supplier']
RADX	Radiopharm Theranostics Limited	100.00	2
SNSE	Sensei Biotherapeutics, Inc.	100.00	2
TLX	Telix Pharmaceuticals Limited	100.00	1	['spend']
NBTX	Nanobiotix S.A.	100.00	2
BSX	Boston Scientific Corporation	100.00	2
AZN	AstraZeneca PLC	100.00	2
ATNM	Actinium Pharmaceuticals, Inc.	100.00	2
CLRB	Cellectar Biosciences, Inc.	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
DRTS	Alpha Tau Medical Ltd.	100.00	1	['spend']
JANX	Janux Therapeutics, Inc.	100.00	2
MTNB	Matinas BioPharma Holdings, Inc.	50.00	2
BTAI	BioXcel Therapeutics, Inc.	14.78	2
STQN	Strategic Acquisitions, Inc.	14.78	2
REGN	Regeneron Pharmaceuticals, Inc.	14.78	2
MNPR	Monopar Therapeutics Inc.	14.78	2

Perspective Therapeutics, Inc. Supply Chain